GetTopicDetailResponse(id=1df12321c0, topicName=ALK重排, introduction=ALK重排, content=null, image=null, comments=0, allHits=1425, url=https://h5.medsci.cn/topic?id=2321, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=11217, tagList=[TagDto(tagId=11217, tagName=ALK重排)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2243378, encodeId=328422433e8f9, content=<a href='/topic/show?id=211e823029d' target=_blank style='color:#2F92EE;'>#肺腺癌#</a> <a href='/topic/show?id=1df12321c0' target=_blank style='color:#2F92EE;'>#ALK重排#</a>, objectTitle=ALK重排早期肺腺癌根治術(shù)后仍具有侵襲性？個(gè)性化輔助治療策略引領(lǐng)更長(zhǎng)生存, objectType=article, longId=855727, objectId=9f12855e2758, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221107/1667834912742_8252897.webp, objectUrl=/article/show_article.do?id=9f12855e2758, replyNumber=0, likeNumber=45, createdTime=2024-12-18, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=9f12855e2758, moduleTitle=ALK重排早期肺腺癌根治術(shù)后仍具有侵襲性？個(gè)性化輔助治療策略引領(lǐng)更長(zhǎng)生存, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9f12855e2758)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2210557, encodeId=d845221055e1e, content=<a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小細(xì)胞肺癌#</a> <a href='/topic/show?id=211e823029d' target=_blank style='color:#2F92EE;'>#肺腺癌#</a> <a href='/topic/show?id=1df12321c0' target=_blank style='color:#2F92EE;'>#ALK重排#</a>, objectTitle=ALK重排NSCLC攜帶KRAS G12C共突變，或與ALK TKI原發(fā)耐藥和迅速進(jìn)展有關(guān), objectType=article, longId=830536, objectId=59f983053626, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240617/1718614376382_5579292.png, objectUrl=/article/show_article.do?id=59f983053626, replyNumber=0, likeNumber=168, createdTime=2024-06-18, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=59f983053626, moduleTitle=ALK重排NSCLC攜帶KRAS G12C共突變，或與ALK TKI原發(fā)耐藥和迅速進(jìn)展有關(guān), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=59f983053626)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2186721, encodeId=c4a42186e2154, content=<a href='/topic/show?id=211e823029d' target=_blank style='color:#2F92EE;'>#肺腺癌#</a> <a href='/topic/show?id=1df12321c0' target=_blank style='color:#2F92EE;'>#ALK重排#</a>, objectTitle=JEM：季紅斌/陳洛南/朱學(xué)良/任勝祥/陳良揭示肺腺鱗癌轉(zhuǎn)分化及其耐藥的分子機(jī)理, objectType=article, longId=812881, objectId=625f8128811f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-in-his-practice-with-a-digital-tablet-UWZKVBN.jpg, objectUrl=/article/show_article.do?id=625f8128811f, replyNumber=0, likeNumber=90, createdTime=2024-02-09, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=625f8128811f, moduleTitle=JEM：季紅斌/陳洛南/朱學(xué)良/任勝祥/陳良揭示肺腺鱗癌轉(zhuǎn)分化及其耐藥的分子機(jī)理, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=625f8128811f)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
